Immunogenicity in Peruvian volunteers of a booster dose of oral cholera vaccine consisting of whole cells plus recombinant B subunit

R. E. Begue, G. Castellares, C. Cabezas, J. L. Sanchez, R. Meza, D. M. Watts, D. N. Taylor

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

14 Citas (Scopus)

Resumen

Forty-nine subjects received two doses of oral cholera vaccine consisting of whole cells plus recombinant B subunit; this was followed by a booster dose one year later. After the primary series, a significant (greater than twofold) increase in the levels of vibriocidal, anti-cholera toxin immunoglobulin G and anti-cholera toxin immunoglobulin A antibodies occurred in 54, 88, and 81% of the subjects, respectively. Within one year, titers decreased to levels close to baseline. A booster dose then induced rises similar to those which occurred after the initial vaccination. The results suggest that 1-year booster doses may be necessary to maintain immunity against cholera in Latin America.

Idioma originalInglés
Páginas (desde-hasta)3726-3728
Número de páginas3
PublicaciónInfection and Immunity
Volumen63
N.º9
DOI
EstadoPublicada - 1995
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Immunogenicity in Peruvian volunteers of a booster dose of oral cholera vaccine consisting of whole cells plus recombinant B subunit'. En conjunto forman una huella única.

Citar esto